You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

Rhinology

On demand events

CEORL-HNS 2022 | Underlying Inflammation in Patients With Severe/Uncontrolled CRSwNP

Profs. Philippe Gevaert and Eugenio De Corso discuss the role of type 2 inflammation in CRSwNP and recent evidence of biologic efficacy.

MD, PhD

Philippe Gevaert +1 more

On demand materials

CEORL-HNS 2022 | Underlying Inflammation in Patients With Severe/Uncontrolled CRSwNP

Rhinology

45 min

expert video

CEORL-HNS 2022 | Underlying Inflammation in Patients With Severe/Uncontrolled CRSwNP

CRSwNP, Type 2 Inflammation, and Mechanisms of Action of Biologics

Rhinology

9 min

expert video

CRSwNP, Type 2 Inflammation, and Mechanisms of Action of Biologics

An Expert View: Defining CRSwNP as Severe and/or Uncontrolled, Discussing Treatment Options, and Partnering With Patients for Optimal Outcomes

Rhinology

21 min

expert video

An Expert View: Defining CRSwNP as Severe and/or Uncontrolled, Discussing Treatment Options, and Partnering With Patients for Optimal Outcomes

Efficacy, Comparative Efficacy, Effectiveness (RWE), and Safety of Treatment Options for Patients With Severe and/or Uncontrolled CRSwNP

Rhinology

14 min

expert video

Efficacy, Comparative Efficacy, Effectiveness (RWE), and Safety of Treatment Options for Patients With Severe and/or Uncontrolled CRSwNP

Learning objectives

Review the role of type 2 inflammation in patients with CRSwNP, focusing on the type 2 mediators that can be targeted by biologics
Understand severe/uncontrolled CRSwNP, treatment options, monitoring of treatment, and shared decision-making with patients
Learn surgical and biological treatment efficacy data for severe/uncontrolled CRSwNP
Review efficacy, real-world effectiveness, and safety profiles of available biologics for patients with severe/uncontrolled CRSwNP

About these experts

Allergy/Immunology

MD, PhD

Philippe Gevaert

Professor of Rhinology and Allergy in the Department of Otorhinolaryngology | Ghent University, Belgium

Rhinology

MD, PhD

Eugenio De Corso

Adjunct Professor of Otorhinolaryngology | Catholic University of the Sacred Heart, Milan, Italy

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region